Andrew Huberman· PhD
"The remission rates on PTSD from properly dosed and spaced MDMA are remarkable, up to somewhere between 60 and 70%."
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
"The remission rates on PTSD from properly dosed and spaced MDMA are remarkable, up to somewhere between 60 and 70%."
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
"The remission rates on PTSD from properly dosed and spaced MDMA are remarkable, up to somewhere between 60 and 70%."
So that work has been done with MDMA therapy for post-traumatic stress disorder. MAPS have led that work and done two phase III trials. I think they've already publicly announced that the second trial had results consistent with the first. We know the results of the first, because they're published and they were remarkably good. Something like 67% remission rates.
the results of of these clinical trials using MDMA for the treatment of PTSD they are incredibly exciting in fact the field of Psychiatry has never before seen the kind of success in treatment of PTSD with any other compound that they are seeing and achieving with the appropriate safe use of MDMA
first the overall rate for clinically effective response to MDMA assisted therapy is 88 that's what's emerging from these trials versus 60 for the placebo and therapy alone
to my knowledge there is no other example of a treatment for a psychiatric disorder that is successful to the same magnitude
an 88 percent success rate and here I'm referring to success rate as a significant reduction in clinical symptoms for PTSD and 67 of those people going into full remittance for PTSD by the end of the treatment is pretty spectacular
what's even more impressive however is that 67 percent of the people in the MDMA plus therapy treatment group no longer met the criteria for PTSD by the end of the treatment
the trials with MDMA and PTSD are incredible what's happening with maps is incredible you know 60 plus perc remission rates done with licensed Physicians of course
the numbers that we were seeing in phase 3 trials were 83 percent cure rate chronic severe ptsd
consistently you're seeing these mass orders of magnitude differential and improvement after and building and this is what we consistently see with most medicine work is that you have this successive and continued building process that happens so after one session to session three session and you compare that consistently between placebo and mdma therapy you see these orders of magnitude better
when psychotherapy was combined with MDMA was something like 70% I mean it just not set a little so which again we could spend just two hours just talking about the role the relationship of trauma and psychological damage and how MDMA can help with that